Search
for
Sort by
Research 661–690 of 1000+
- S3 guideline diagnostics and therapy in alopecia areata – Part 2: Therapy, psychosocial and cosmetic support
- Follicular Vitiligo: A Rare and Under Recognized Variant
- Alopecia Areata: Unseen Burdens and Unmet Needs – Comment on ‘The most impactful aspects of living with alopecia areata among patients commencing systemic treatments: Evaluating patients’ perspectives to guide therapy’
- More than cosmetic: A personal perspective on alopecia areata and therapeutic restoration
- The Possible Role of Antibodies in Alopecia: A Narrative Review
- CURRENT UNDERSTANDING OF VITILIGO: A COMPREHENSIVE LITERATURE REVIEW
- Consensus Document on the Clinical Management of Alopecia Areata: Recommendations from the Spanish Hair Research Group of the Spanish Academy of Dermatology and Venerology)
- Case Report: Vitiligo and Alopecia Universalis Following Rituximab Therapy in a Patient with Myasthenia Gravis
- Alopecia and Mental Health: Psychosocial Burden, Neuroendocrine Mechanisms, and Therapeutic Implications
- Alopecia and Mental Health: Psychosocial Burden, Neuroendocrine Mechanisms, and Therapeutic Implications
- Stem cell-based therapies for alopecia areata: a narrative review
- Alopecia Areata: A Comprehensive Review of Pathogenesis, Diagnosis, and Emerging Therapeutics
- Dupilumab Associated Progression of Alopecia Areata to Alopecia Universalis: A Case Report
- Is female-pattern hair loss an autoimmune-like disorder? Unveiling the “silent” inflammation
- Hair restoration and regenerative medicine: Scope, science, and the road ahead
- Tangled Causes, Targeted Solutions: A Comprehensive Review of Alopecia.
- A Comprehensive Bibliometric Analysis of Global Research Trends in Hair Loss Treatment: Key Contributions, Emerging Hotspots, and Future Directions
- Insights into the Diagnostics and Therapeutics of Alopecia Areata—An Indian Context
- Immune Regulation in Hair Follicle Protection and Hair Regeneration: Insights from the Collapse of Immune Privilege in Alopecia Areata and Targeted Immunotherapy
- Revisión y avances en tricología
- Therapeutic Approaches for Alopecia Areata in Children Aged 6 to 11 Years
- 93 Approach to Managing Recalcitrant Alopecia Areata With Combination Therapy: A Series of Five Cases in Black Pediatric Patients
- Psychophysiological Mechanisms of Stress Impact on Hair Loss Processes
- To Treat or Not to Treat: Two Roads Traveled With Alopecia Areata
- Post-COVID-19 Alopecia Universalis: Autoimmune Hair Loss and the Challenge of Relapse Management.
- Circulating MicroRNA Signatures in Severe Alopecia Areata: Diagnostic Discrimination, Pathway Analysis, and Therapeutic Implications
- Adjunctive Dupilumab Therapy in a Partial Responder to Baricitinib for Alopecia Areata
- A Case Study on Exploring Immune Dysregulation in Alopecia Areata - Mechanisms and Treatments Outcomes
- BH17 Bridging the gap: identifying dual-targeting therapies for patients with alopecia areata and coexisting immune-mediated inflammatory diseases
- VITILIGO: WHAT’S OLD, WHAT’S NEW?